Study | Number of patients/aneurysms | Complete occlusion | Adequate occlusion | Unruptured/ruptured | Use of additional stents/coiling/SAC |
Lubicz et al 24 | 45/45 | 9/37 (24.3%) | 30/37 (81.1%) | 42/3 | 4/2/0 |
Pierot et al 25 | 33/34 | 8/30 (26.7%) | 25/30 (83.3%) | 29/5 | 2/2/0 |
Clajus et al 8 | 108/114 | 52/90 (57.8%) | 68/90 (75.6%) | 67/47 | 4/6/3 |
Liebig et al 6 | 47/52 | 15/25 (60%) | 20/25 (80.0%) | 0/52 | 4/2/1 |
Papagiannaki et al 26 | 83/85 | 37/65 (56.9%) | 60/65 (92.3%) | 81/4 | 0/7/2 |
Behme et al 27 | 52/55 | 15/44 (34.1%) | 29/44 (65.9%) | 41/14 | NR |
Herbreteau et al 19 | 39/39 | 23/38 (60.5%) | 33/38 (86.8%) | 35/4 | 2/0/0 |
Caroff et al 28 | 90/98 | NR | 45/69 (65.2%) | 65/33 | 5/7/0 |
Pierot et al 9 | 168/169 | 81/153 (52.9%) | 121/153 (79.1%) | 155/14 | 5/7/0 |
Van Rooij et al 29 | 51/59 | 41/57 (71.9%) | 53/57 (93.0%) | 59/0 | 0/0/0 |
Van Rooij et al 30 | 40/46 | 28/39 (71.8%) | 37/39 (94.9%) | 21/25 | 0/0/0 |
Popielski et al 31 | 101/102 | 47/78 (60.3%) | 63/78 (80.8%) | 65/37 | 7/7/1 |
Van Rooij et al 7 | 100/100 | 54/74 (73.0%) | 71/74 (95.9%) | 0/100 | 0/0/0 |
Present study | 113/114 | 61/98 (62.2%) | 82/98 (83.7%) | 78/36 | 15/6/5 |
NR, not reported; SAC, stent-assisted coiling.